Dai­ichi Sankyo los­es bid to bat back a $42M patent ver­dict over En­her­tu

Af­ter a ju­ry award­ed Seagen near­ly $42 mil­lion and found Dai­ichi Sankyo in­fringed on its patent in the de­vel­op­ment of En­her­tu, Dai­ichi ap­pealed the de­ci­sion to try to stop the ver­dict’s en­force­ment. But the com­pa­ny found no luck there, ei­ther.

Dai­ichi Sankyo lost a chal­lenge to the rul­ing Tues­day, as the East­ern Dis­trict Court of Texas dis­agreed with its claims that the patent in­volved couldn’t be en­forced. Judge Rod­ney Gilstrap up­held the pre­vi­ous de­ci­sion, which found Dai­ichi will­ful­ly in­fringed on patents re­lat­ed to Seagen’s an­ti­body-drug con­ju­gate tech­nol­o­gy in cre­at­ing En­her­tu.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.